Results 141 to 150 of about 28,302,100 (317)
Quarterly Report to the Technology Assessment Board, January 1 - March 31, 1980
This is a quarterly report detailing the budget and progress of the Office of Technology ...
Office of Technology Assessment
core
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani +9 more
wiley +1 more source
Quarterly Report to the Technology Assessment Board, October 1 - December 31, 1990
This is a quarterly report detailing the budget and progress of the Office of Technology ...
Office of Technology Assessment
core
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira +7 more
wiley +1 more source
Quarterly Report to the Technology Assessment Board, January 1 - March 31, 1987
Quarterly report to the Technology Assessment Board, detailing progress and budgets at ...
Office of Technology Assessment
core
In head and neck squamous cell carcinoma (HNSCC) p53 and p63 exert opposite roles on the transcription regulation of the lncRNA NEAT1. Under basal conditions, p53 levels are low and p63 represses NEAT1 expression. Upon genotoxic stress, p53 is rapidly induced, displacing p63 from the NEAT1 promoter leading to NEAT1 transcriptional activation and ...
Sara De Domenico +5 more
wiley +1 more source
Quarterly Report Office of Technology Assessment, October 1 - December 1, 1984
Quarterly report detailing the budget and progress of the Office of Technology ...
Office of Technology Assessment
core
This study identifies ARHGAP5, in addition to the frequently mutated ARHGAP35, as significantly mutated in endometrial cancer. Mutations in both genes co‐occur and are associated with their correlated downregulation. Functional CRISPR studies show that both paralogs regulate similar pathways, including actin cytoskeleton organization.
Mathilde Pinault +12 more
wiley +1 more source
Quarterly Report to the Technology Assessment Board, April 1 - June 30, 1980
This is a quarterly report detailing the budget and progress of the Office of Technology ...
Office of Technology Assessment
core

